PABSA

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePABSA
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type B antagonistsEndothelin receptor type A antagonists
TargetsEndothelin receptor type BEndothelin receptor type A
Therapy Area/IndicationsHeart FailureHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesShionogi & Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShionogi & Co Ltd
Active IndicationsN/A
Inactive IndicationsHeart FailureHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A